← back to search

Nardev S. Khurmi

Sanofi (United States) · US
Area of research
Cardiology and Cardiovascular Medicine · Analytical Chemistry
Research interest
Research interests include Cardiac electrophysiology and arrhythmias, Cardiac pacing and defibrillation studies, Analytical Methods in Pharmaceuticals, and Cardiac Imaging and Diagnostics.
h-index
22
citations
4,505
works
55
NIH funding
primary concept
Medicine
email

Recent publications

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
The Lancet Diabetes & Endocrinology 2021cited by 1,451position: middledoi
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
New England Journal of Medicine 2021cited by 756position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hertzel C. Gerstein · McMaster University2 papers (2021–2021)Julio Rosenstock · Dallas Diabetes Research Center2 papers (2021–2021)Richard E. Pratley · AdventHealth Translational Research Institute2 papers (2021–2021)Renato D. Lópes · Alnylam Pharmaceuticals (United States)2 papers (2021–2021)Carolyn S.P. Lam · Duke-NUS Medical School2 papers (2021–2021)Kelley R. Branch · University of Washington2 papers (2021–2021)Stefano Del Prato · Fondazione Toscana Gabriele Monasterio2 papers (2021–2021)John J.V. McMurray · University of Glasgow1 papers (2021–2021)Matthew M.Y. Lee · British Heart Foundation1 papers (2021–2021)Leanne Dyal · Population Health Research Institute1 papers (2021–2021)Chinthanie Ramasundarahettige · Hamilton Health Sciences1 papers (2021–2021)Laura Heenan · Population Health Research Institute1 papers (2021–2021)Søren Lund Kristensen · Georgetown University1 papers (2021–2021)